Dudediligence.

Charles River Laboratories International, Inc

CRLNYSE · Services-Commercial Physical & Biological Research
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.01BSep ’24$1.00BDec ’24$984.2MMar ’25$1.03BJun ’25$1.00BSep ’25$994.2MDec ’25$995.8MMar ’26$1.00BJun ’26
Net income, by quarter
$69.7MSep ’24−$214.5MDec ’24$25.5MMar ’25$52.3MJun ’25$54.4MSep ’25−$276.6MDec ’25−$14.8MMar ’26−$1.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$3.54B$3.98B$4.13B$4.05B$4.02B
Operating income$589.9M$651.0M$617.3M$227.3M$25.2M
Net income$391.0M$486.2M$474.6M$22.2M−$144.3M
Operating cash flow$760.8M$619.6M$683.9M$734.6M$737.6M
Free cash flow$532.0M$294.9M$365.4M$501.6M$518.5M
Cash$241.2M$233.9M$276.8M$194.6M$213.8M
Debt$2.67B$2.71B$2.65B$2.24B$2.14B
Shares outstanding50.5M50.9M51.3M51.1M49.2M
CRL fundamentals · DudeDiligence